Bergen Brunswig Corporation

Teva says it isn’t worried about the more aggressive pricing strategies used by brand companies to blunt blockbuster generic launches. What if the world’s largest generic company is wrong? Ramsey Bagh

A look at financing, M&A, and alliance activity in January 2001-March 2001 In this issue we are presenting another installment of our quarterly review of dealmaking—in this case January to March 2001.

Laser companies hope to disassociate themselves from the pronouncement by cardiologist Martin Leon that direct myocardial revascularization is dead. by Mary Stuart Suffice it to say, cardiologist Mart

Bergen Brunswig Corp. 's recent announcement that it would sell the specialty pharmacy assets of its Stadtlander Drug Co. Inc. subsidiary [See Deal] hardly comes as a surprise. In January 1999,